2020
3:00 PM Abstract No. 190 ■ FEATURED ABSTRACT Quantifying the immune response after combined immuno-thermal ablation in a murine model of colorectal cancer
Slovak R, Park H, Kamp W, Ludwig J, Kang I, Kim K. 3:00 PM Abstract No. 190 ■ FEATURED ABSTRACT Quantifying the immune response after combined immuno-thermal ablation in a murine model of colorectal cancer. Journal Of Vascular And Interventional Radiology 2020, 31: s87. DOI: 10.1016/j.jvir.2019.12.229.Peer-Reviewed Original ResearchQuantification of immune response after dual checkpoint inhibition in a microsatellite stable model of colorectal cancer.
Kamp W, Park H, Slovak R, Ludwig J, Kang I, Kim H. Quantification of immune response after dual checkpoint inhibition in a microsatellite stable model of colorectal cancer. Journal Of Clinical Oncology 2020, 38: 160-160. DOI: 10.1200/jco.2020.38.4_suppl.160.Peer-Reviewed Original ResearchDual immune checkpoint blockadeAnti-PD-1 antibodyColorectal cancerPD-1T cellsImmune responseMurine colorectal cancer cellsBALB/c miceDual checkpoint inhibitionExpression of TIM3Subcutaneous flank injectionNumber of CD8PD-1 inhibitionImmune checkpoint blockadeDeficient mismatch repairColorectal cancer cellsHigh microsatellite instabilitySignificant clinical impactPotential escape mechanismsCombination immunotherapyImmunosuppressive checkpointsCheckpoint inhibitorsMonotherapy groupCheckpoint blockadeMost patientsSystemic impact on tumor growth after combined immuno-thermal ablation in a murine model of colorectal cancer.
Slovak R, Park H, Kamp W, Ludwig J, Kang I, Kim H. Systemic impact on tumor growth after combined immuno-thermal ablation in a murine model of colorectal cancer. Journal Of Clinical Oncology 2020, 38: 198-198. DOI: 10.1200/jco.2020.38.4_suppl.198.Peer-Reviewed Original ResearchDual immune checkpoint blockadeTreatment days 0Target tumorTumor volumeDay 0Anti-cancer immune responseBALB/c miceAddition of immunotherapyImmune checkpoint blockadeTreatment day 2Colorectal cancer cellsInjection of antibodiesFull ablationCheckpoint blockadeColorectal cancerC miceSham injectionMean changeImmune responseMurine modelControl animalsCryoablationDay 2Tumor growthFlank injection
2018
Interleukin-1 and IL-23 induce innate-like immune responses by bystander-activated memory CD4+ T cells contributing to the autoimmune pathogenesis
Lee H, Lee J, Kang I, Choi J. Interleukin-1 and IL-23 induce innate-like immune responses by bystander-activated memory CD4+ T cells contributing to the autoimmune pathogenesis. The Journal Of Immunology 2018, 200: 51.7-51.7. DOI: 10.4049/jimmunol.200.supp.51.7.Peer-Reviewed Original ResearchT cellsT cell antigen receptorIL-17AIL-23Memory CD4IL-1βImmune responseAutoimmune disease pathogenesisPro-inflammatory cytokinesIFN-γ expressionNaïve T cellsT cell activationAutoimmune neuroinflammationImmunopathological roleTh17 cellsAutoimmune pathogenesisBystander activationBystander CD4T lymphocytesIL-1Interleukin-1CD4Disease pathogenesisCell activationCell antigen receptor
2012
1,25-Dihyroxyvitamin D3 Promotes FOXP3 Expression via Binding to Vitamin D Response Elements in Its Conserved Noncoding Sequence Region
Kang SW, Kim SH, Lee N, Lee WW, Hwang KA, Shin MS, Lee SH, Kim WU, Kang I. 1,25-Dihyroxyvitamin D3 Promotes FOXP3 Expression via Binding to Vitamin D Response Elements in Its Conserved Noncoding Sequence Region. The Journal Of Immunology 2012, 188: 5276-5282. PMID: 22529297, PMCID: PMC3358577, DOI: 10.4049/jimmunol.1101211.Peer-Reviewed Original ResearchConceptsFoxp3 expressionT cellsVD receptorFOXP3 geneVD response elementsTreg cellsIL-2Foxp3-positive regulatory T cellsFoxp3 promoter activityHuman FOXP3 geneRegulatory T cellsImmune regulatory propertiesInhibitory functionHuman immune responseVitamin D response elementTCR triggeringD response elementImmune cellsImmune responseResponse elementUnique subsetRetinoic acidProliferation of targetsCellsExpression
2006
CHAPTER 28 Systemic Lupus Erythematosus: Immunologic Features
KANG I, CRAFT J. CHAPTER 28 Systemic Lupus Erythematosus: Immunologic Features. 2006, 357-367. DOI: 10.1016/b978-012595961-2/50031-7.Peer-Reviewed Original ResearchSystemic lupus erythematosusPlasmacytoid dendritic cellsT cellsAdaptive immunityImmune complexesAberrant innate immune responsesAdaptive immune cellsUpregulation of IFNSubsequent tissue injuryPeripheral blood cellsInnate immune responseActivation of complementRespective autoantigensDendritic cellsLupus erythematosusData support rolesImmune cellsSerologic hallmarkTissue injuryClinical diseaseImmune responseTarget organsFc receptorsB cellsImmune system
2005
Altered IL-7Rα expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses
Kim HR, Hong MS, Dan JM, Kang I. Altered IL-7Rα expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood 2005, 107: 2855-2862. PMID: 16357322, PMCID: PMC1440715, DOI: 10.1182/blood-2005-09-3560.Peer-Reviewed Original ResearchConceptsIL-7 therapyT cellsT cell receptorIL-7T cell immune responsesEffector memory CD8T cell immunityT cell subsetsIL-7Rα expressionDiverse TCR repertoireIL-7Ralpha expressionIL-7Ralpha mRNAMemory CD8TCR repertoireElderly subjectsCD8Immune responseSurvival responseYoung subjectsImpaired signalingSTAT5 phosphorylationTherapyProtein alphaSurvival pathwaysCells
2004
Age-Associated Change in the Frequency of Memory CD4+ T Cells Impairs Long Term CD4+ T Cell Responses to Influenza Vaccine
Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft J. Age-Associated Change in the Frequency of Memory CD4+ T Cells Impairs Long Term CD4+ T Cell Responses to Influenza Vaccine. The Journal Of Immunology 2004, 173: 673-681. PMID: 15210831, DOI: 10.4049/jimmunol.173.1.673.Peer-Reviewed Original ResearchConceptsT cell responsesIL-7 levelsMemory CD4Long-term CD4T cellsCell responsesInfluenza vaccineIFN-gammaInfluenza virus-specific CD4Serum IL-7 levelsEM cellsLevels of CD4Virus-specific CD4Central memory CD4Effector memory CD4Cellular immune responsesFrequency of influenzaImportant clinical questionsAge-Associated ChangesEM CD4Influenza vaccinationTNF-alphaVaccination strategiesIL-7Immune response
2003
Infectious complications in SLE after immunosuppressive therapies
Kang I, Park S. Infectious complications in SLE after immunosuppressive therapies. Current Opinion In Internal Medicine 2003, 2: 629-635. DOI: 10.1097/00132980-200302060-00015.Peer-Reviewed Original ResearchSystemic lupus erythematosusMannose-binding lectin variant allelesHigh-dose glucocorticoidsImmunosuppressive therapyLupus erythematosusInfectious complicationsMycophenolate mofetilImmunosuppressive drugsRisk factorsVariant allelesMannose-binding lectin deficiencyMajor organ involvementUse of steroidsCommon viral infectionsExtrinsic risk factorsStrong risk factorIncidence of infectionHerpes zosterOrgan involvementSerious infectionsLectin deficiencyErythematosusImmune responsePatientsViral infectionInfectious complications in SLE after immunosuppressive therapies
Kang I, Park S. Infectious complications in SLE after immunosuppressive therapies. Current Opinion In Internal Medicine 2003, 2: 629-635. DOI: 10.1097/00132980-200312000-00015.Peer-Reviewed Original ResearchSystemic lupus erythematosusMannose-binding lectin variant allelesHigh-dose glucocorticoidsImmunosuppressive therapyLupus erythematosusInfectious complicationsMycophenolate mofetilImmunosuppressive drugsRisk factorsVariant allelesMannose-binding lectin deficiencyMajor organ involvementUse of steroidsCommon viral infectionsExtrinsic risk factorsStrong risk factorIncidence of infectionHerpes zosterOrgan involvementSerious infectionsLectin deficiencyErythematosusImmune responsePatientsViral infection